A Correlation Between Hair Cortisol Levels and the Development of Post Traumatic Stress Disorder (PTSD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02033395|
Recruitment Status : Unknown
Verified January 2014 by Sheba Medical Center.
Recruitment status was: Not yet recruiting
First Posted : January 10, 2014
Last Update Posted : January 10, 2014
This observational study follows subjects who have been exposed to a traumatic event and are at risk of developing PTSD symptoms. Participants are recruited within six hours of a traumatic event, and, starting from the recruitment session, are then examined on six set points of time within a period of thirteen months. The examinations include both biological studies of cortisol in hair, blood and saliva, and psychological examinations and questionaires that assess the development and severity of PTSD symptoms.
The novel method of sampling hair cortisol allows investigators to retroactively estimate the mean levels of blood cortisol during the tree months prior to the sampling.
The study aims at further illuminating the correlation between cortisol levels both prior and following a traumatic event, and the development and severity of PTSD symptoms
|Condition or disease|
|Post Traumatic Stress Disorder|
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||A Correlation Between Hair Cortisol Levels and the Development of Post Traumatic Stress Disorder (PTSD)|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||January 2016|
|Participants exposed to tramautic event|
- PTSD diagnosis and symptom severity as measured by Clinician Administered PTSD Scale (CAPS). [ Time Frame: 13 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02033395
|Contact: Eldor Rogev, MDfirstname.lastname@example.org|
|Chaim Sheba Medical Center|
|Tel Hashomer, Israel, 52621|
|Contact: Eldor Rogev, MD 972-3-5303300 email@example.com|
|Sub-Investigator: Eldor Rogev, MD|
|Principal Investigator: Joseph Zohar, MD|